Search Result "CDK-6"
Molecular Dynamics Mechanisms of the Inhibitory Effects of Abemaciclib, Hymenialdisine, and Indirubin on CDK-6
Journal: Current Drug Research Reviews
Volume: 11 Issue: 2 Year: 2019 Page: 135-141
Author(s): Gholam Basati,Javad Saffari-Chaleshtori,Saber Abbaszadeh,Majid Asadi-Samani,Korosh Ashrafi-Dehkordi
The Molecular Docking and Molecular Dynamic Effects of Omeprazole on CDKs 2, 4, and 6 as a Potential CDK Inhibitor in Cancer Treatment
Journal: Current Cancer Therapy Reviews
Volume: 21 Issue: 1 Year: 2025 Page: 110-117
Author(s):
Identification of Novel CDK 4/6 Inhibitors by High-throughput Virtual Screening
Journal: Letters in Drug Design & Discovery
Volume: 21 Issue: 15 Year: 2024 Page: 3229-3246
Author(s):
An Overview of CDK Enzyme Inhibitors in Cancer Therapy
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 8 Year: 2023 Page: 603-619
Author(s): Honnavalli Yogish Kumar
Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 2 Year: 2005 Page: 167-179
Author(s): Hiroshi Hirai, Nobuhiko Kawanishi, Yoshikazu Iwasawa
Progress of CDK4/6 Inhibitor Palbociclib in the Treatment of Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 9 Year: 2018 Page: 1241-1251
Author(s): Fengquan Chen,Chunxi Liu,Jian Zhang,Wenfang Xu,Yingjie Zhang
Naturally Sourced CDK Inhibitors and Current Trends in Structure-Based SyntheticAnticancer Drug Design by Crystallography
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 3 Year: 2022 Page: 485-498
Author(s): Sisir Nandi,Rishita Dey,Sudatta Dey,Asmita Samadder,Anil Kumar Saxena
Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 342-358
Author(s): G. Nemeth, Z. Varga, Z. Greff, G. Bencze, A. Sipos, C. Szantai-Kis, F. Baska, A. Gyuris, K. Kelemenics, Z. Szathmary, J. Minarovits, G. Keri, L. Orfi
Recent Advances in the Development of Selective Small Molecule Inhibitors for Cyclin-Dependent Kinases
Ebook: Frontiers in Medicinal Chemistry
Volume: 4 Year: 2009
Author(s):
Doi: 10.2174/978160805207310904010347
Recent Advances in Cyclin-Dependent Kinase Inhibition. Purine-Based Derivatives as Anti-Cancer Agents. Roles and Perspectives for the Future
Journal: Current Topics in Medicinal Chemistry
Volume: 2 Issue: 9 Year: 2002 Page: 1037-1050
Author(s): Jean-luc Haesslein, Nathalie Jullian